...
首页> 外文期刊>Journal of psychopharmacology >Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
【24h】

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.

机译:非典型抗精神病药可以改善与其他非典型抗精神病药相关的迟发性运动障碍吗?病例报告和文献简要回顾。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Tardive dyskinesia (TD) is a devastating adverse effect of long-term antipsychotic drug treatment. Atypical antipsychotics produce less TD, and it has been shown that they may have a therapeutic effect on pre-existing TD. Here, we report a case of olanzapine-induced TD which did not improve after switching to risperidone but improved after the addition of quetiapine to risperidone regimen. We also provide a brief review of the reported cases on TD induced by atypical antipsychotics which improved after switching to another atypical agent. It is unclear whether some atypical antipsychotics are more effective than others in the treatment of TD. Differences in this property and the underlying mechanism require further study.
机译:迟发性运动障碍(TD)是长期抗精神病药物治疗的毁灭性不良反应。非典型抗精神病药产生的TD较少,并且已显示它们可能对已有的TD有治疗作用。在这里,我们报告一例奥氮平诱导的TD,在改用利培酮后并未改善,但在喹硫平方案中加入了喹硫平后却有所改善。我们还简要概述了由非典型抗精神病药诱发的TD报道病例,该病在改用另一种非典型药物后有所改善。目前尚不清楚某些非典型抗精神病药在治疗TD方面是否比其他抗精神病药更有效。此属性和潜在机制的差异需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号